Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Nutr ; 60(8): 4189-4202, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34550452

RESUMO

PURPOSE: Gargling with tea has protective effects against influenza infection and upper respiratory tract infection (URTI). To evaluate if tea and tea catechin consumption has the same protective effects as gargling with tea, we performed a systematic review and meta-analysis. METHODS: We performed a comprehensive literature search using the PubMed, Cochrane Library, Web of Science, and Ichu-shi Web databases. The search provided six randomized controlled trials (RCTs) and four prospective cohort studies (n = 3748). The quality of each trial or study was evaluated according to the Cochrane risk-of-bias tool or Newcastle-Ottawa Scale. We collected data from publications meeting the search criteria and conducted a meta-analysis of the effect of tea gargling and tea catechin consumption for preventing URTI using a random effects model. RESULTS: Tea gargling and tea catechin consumption had significant preventive effects against URTI (risk ratio [RR] = 0.74, 95% confidence interval [CI] 0.64-0.87). In sub-analyses, a significant preventive effect was observed by study type (prospective cohort study: RR = 0.67, 95% CI 0.50-0.91; RCT: RR = 0.79, 95% CI 0.66-0.94) and disease type (influenza: RR = 0.69, 95% CI 0.58-0.84; acute URTI: RR = 0.78, 95% CI 0.62-0.98). Both gargling with tea and consuming tea catechins effectively protected against URTI (tea and tea catechins consumption: RR = 0.68, 95% CI 0.52-0.87; tea gargling: RR = 0.83, 95% CI 0.72-0.96). CONCLUSION: Our findings suggest that tea gargling and tea catechin consumption may have preventive effects against influenza infection and URTI. The potential effectiveness of these actions as non-pharmaceutical interventions, however, requires further investigation.


Assuntos
Catequina , Influenza Humana , Infecções Respiratórias , Humanos , Influenza Humana/prevenção & controle , Razão de Chances , Infecções Respiratórias/prevenção & controle , Chá
2.
Pigment Cell Melanoma Res ; 27(5): 754-63, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24890809

RESUMO

Rhododendrol, an inhibitor of melanin synthesis developed for lightening/whitening cosmetics, was recently reported to induce a depigmentary disorder principally at the sites of repeated chemical contact. Rhododendrol competitively inhibited mushroom tyrosinase and served as a good substrate, while it also showed cytotoxicity against cultured human melanocytes at high concentrations sufficient for inhibiting tyrosinase. The cytotoxicity was abolished by phenylthiourea, a chelator of the copper ions at the active site, and by specific knockdown of tyrosinase with siRNA. Hence, the cytotoxicity appeared to be triggered by the enzymatic conversion of rhododendrol to active product(s). No reactive oxygen species were detected in the treated melanocytes, but up-regulation of the CCAAT-enhancer-binding protein homologous protein gene responsible for apoptosis and/or autophagy and caspase-3 activation were found to be tyrosinase dependent. These results suggest that a tyrosinase-dependent accumulation of ER stress and/or activation of the apoptotic pathway may contribute to the melanocyte cytotoxicity.


Assuntos
Butanóis/toxicidade , Monofenol Mono-Oxigenase/metabolismo , Pigmentação/efeitos dos fármacos , Preparações Clareadoras de Pele/toxicidade , Agaricales/enzimologia , Apoptose , Butanóis/química , Caspase 3/metabolismo , Domínio Catalítico , Sobrevivência Celular , Células Cultivadas , Quelantes/química , Cobre/química , Estresse do Retículo Endoplasmático , Elementos Facilitadores Genéticos , Ensaio de Imunoadsorção Enzimática , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Humanos , Hipopigmentação/induzido quimicamente , Concentração Inibidora 50 , Interleucina-8 , Melanócitos/citologia , Melanócitos/efeitos dos fármacos , Monofenol Mono-Oxigenase/antagonistas & inibidores , Monofenol Mono-Oxigenase/química , Feniltioureia/química , RNA Interferente Pequeno/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Preparações Clareadoras de Pele/química , Regulação para Cima , Vitiligo/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa